Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
Other names: National Institute for Pharmaceutical Technology and Educa; National Institute for Pharmaceutical Technology and Education
EIN 26-0636598 · Snapshot of IRS recognition, filing currency, financial health, and governance.
The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, Technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
Principal Officer
Vadim J Gurvich
Total Revenue
$3.0M
FY2023
Total Expenses
$4.0M
FY2023
Net Assets
$482K
Program Ratio
95.1%
expenses on programs
Employees
0
Volunteers
0
Board Members
15
Voting
0
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.